a double-blind randomised , parallel , placebo-controlled study was performed in patients with congestive heart failure , at 13 centres in 10 countries , to assess the efficacy and safety of lisinopril , a new angiotensin-converting enzyme inhibitor .
C0018802
congestive heart failure
C0065374
lisinopril